Back to Boston Trust Walden Corp Boston Trust Walden Corp

GMEDGMED
Showing 7 of 29 quarters

Position history for Boston Trust Walden CorpBoston Trust Walden Corp's holdings in GLOBUS MED INC

Boston Trust Walden Corp holds 1.6M shares of GMED (GLOBUS MED INC), worth $124.3M as of 2026-Q2. The position was increased (+25.4% shares). GMED represents 0.9% of Boston Trust Walden Corp's portfolio.

Current Value

$124.3M

Current Shares

1.6M

Total Value Change

+$72.1M

Total Shares Change

+843,437

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.6M
+25.4%
$124.3M0.9%$79.01
52
2026-Q1
Decreased
1.3M
-8.3%
$108.1M0.9%$91.70
0
2025-Q4
Increased
1.4M
+15.4%
$119.4M0.9%$87.91
49
2025-Q3
New
1.2M
-
$67.9M0.5%$56.42
49
2025-Q1
Exited
0
-100.0%
$00.0%$72.55
0
2024-Q4
Decreased
619,652
-15.1%
$51.3M0.4%$82.67
0
2024-Q3
Decreased
729,924
-2.4%
$52.2M0.4%$70.61
0

Other major holders of GMED: BNP PARIBAS FINANCIAL MARKETS, VANGUARD GROUP INC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used